0001225208-21-010280.txt : 20210706 0001225208-21-010280.hdr.sgml : 20210706 20210706161247 ACCESSION NUMBER: 0001225208-21-010280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210701 FILED AS OF DATE: 20210706 DATE AS OF CHANGE: 20210706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WICHMANN DAVID S CENTRAL INDEX KEY: 0001268489 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 211074207 MAIL ADDRESS: STREET 1: UNITEDHEALTH GROUP INC STREET 2: 9900 BREN RD E CITY: MINNETONKA STATE: MN ZIP: 55343 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2021-07-01 0000885725 BOSTON SCIENTIFIC CORP BSX 0001268489 WICHMANN DAVID S 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 Deferred Stock Units 2021-07-01 4 A 0 4093.0000 0.0000 A Common Stock 4093.0000 4093.0000 D Deferred Stock Units 2021-07-01 4 A 0 2296.0000 0.0000 A Common Stock 2296.0000 6389.0000 D Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Reflects a value of approximately $177,500 (representing the prorated amount of the non-employee director compensation program's annual equity grant having a value of $205,000) divided by the closing price of common stock on the date of grant. Grant of deferred stock units to non-employee director following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of approximately $99,600 (representing the prorated amount of the non-employee director compensation program's cash retainer having a value of $115,000) divided by the closing price of the common stock on the date of grant. Grant of deferred stock units in lieu of yearly cash compensation following initial appointment to the Board of Directors, which, pursuant to the Company's non-employee director compensation program, has been prorated for the time period from the effective date of the appointment to the date of the Company's 2022 annual meeting of stockholders. The grant of deferred stock units vests in full upon the next annual meeting of stockholders. Vested shares will be issued to the reporting person following the reporting person's separation from Board of Director service, in accordance with the Company's Non-Employee Director Deferred Compensation Plan. /s/ Mai-Khoi Nguyen-Thanh, Attorney-in-Fact 2021-07-06